Company News
Sionna Cuts 46% Workforce, Targets CF Drug
Sionna Therapeutics' shares fell about 3% in after‑hours trading after announcing a 46% reduction in its workforce.
The company will pivot to a dual cystic fibrosis combination, SION‑451 + SION‑2222,
